NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $625,812 | +2.4% | 6,198 | +3.3% | 0.28% | -5.0% |
| Q3 2023 | $610,956 | -0.7% | 5,998 | -1.6% | 0.30% | +3.8% |
| Q2 2023 | $615,349 | +7.9% | 6,098 | -1.6% | 0.29% | +2.5% |
| Q1 2023 | $570,400 | -3.3% | 6,200 | -4.6% | 0.28% | 0.0% |
| Q4 2022 | $589,680 | +17.5% | 6,500 | -1.5% | 0.28% | +12.4% |
| Q3 2022 | $502,000 | -1.0% | 6,600 | +10.0% | 0.25% | 0.0% |
| Q2 2022 | $507,000 | -0.4% | 6,000 | +3.4% | 0.25% | +3.3% |
| Q1 2022 | $509,000 | +9.7% | 5,800 | +9.4% | 0.24% | +9.5% |
| Q4 2021 | $464,000 | +7.2% | 5,300 | 0.0% | 0.22% | -3.1% |
| Q3 2021 | $433,000 | -4.2% | 5,300 | +8.2% | 0.23% | -12.3% |
| Q2 2021 | $452,000 | -0.2% | 4,900 | -5.8% | 0.26% | -8.8% |
| Q1 2021 | $453,000 | -7.7% | 5,200 | 0.0% | 0.28% | -8.4% |
| Q4 2020 | $491,000 | +34.5% | 5,200 | +23.8% | 0.31% | +23.4% |
| Q3 2020 | $365,000 | -7.1% | 4,200 | -6.7% | 0.25% | -15.2% |
| Q2 2020 | $393,000 | +25.6% | 4,500 | +18.4% | 0.30% | +2.8% |
| Q1 2020 | $313,000 | -39.9% | 3,800 | -30.9% | 0.29% | -28.8% |
| Q4 2019 | $521,000 | +7.0% | 5,500 | -1.8% | 0.41% | -5.4% |
| Q3 2019 | $487,000 | +0.6% | 5,600 | +5.7% | 0.43% | +10.3% |
| Q2 2019 | $484,000 | -6.7% | 5,300 | -1.9% | 0.39% | -3.0% |
| Q1 2019 | $519,000 | +54.9% | 5,400 | +38.5% | 0.40% | +77.4% |
| Q4 2018 | $335,000 | -19.1% | 3,900 | -18.8% | 0.23% | +4.1% |
| Q3 2018 | $414,000 | +11.9% | 4,800 | -2.0% | 0.22% | +9.6% |
| Q2 2018 | $370,000 | +1.6% | 4,900 | +8.9% | 0.20% | -2.5% |
| Q1 2018 | $364,000 | -13.3% | 4,500 | -10.0% | 0.20% | -14.0% |
| Q4 2017 | $420,000 | +43.8% | 5,000 | +47.1% | 0.24% | +43.9% |
| Q3 2017 | $292,000 | +19.2% | 3,400 | +9.7% | 0.16% | -0.6% |
| Q3 2016 | $245,000 | -58.8% | 3,100 | -56.9% | 0.16% | -61.1% |
| Q2 2016 | $594,000 | +3.8% | 7,200 | -8.9% | 0.42% | +0.5% |
| Q1 2016 | $572,000 | -26.1% | 7,900 | -12.2% | 0.42% | -27.0% |
| Q4 2015 | $774,000 | -1.1% | 9,000 | -43.8% | 0.58% | -8.8% |
| Q3 2015 | $783,000 | -4.9% | 16,000 | +95.7% | 0.63% | -5.4% |
| Q2 2015 | $823,000 | -9.3% | 8,177 | -11.1% | 0.67% | -10.1% |
| Q1 2015 | $907,000 | -45.2% | 9,200 | -47.0% | 0.74% | -6.1% |
| Q4 2014 | $1,654,000 | – | 17,362 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |